Skip to main content
Top
Published in: Antimicrobial Resistance & Infection Control 1/2012

Open Access 01-12-2012 | Research

Prolongation of length of stay and Clostridium difficile infection: a review of the methods used to examine length of stay due to healthcare associated infections

Authors: Brett G Mitchell, Anne Gardner

Published in: Antimicrobial Resistance & Infection Control | Issue 1/2012

Login to get access

Abstract

Background

It is believed that Clostridium difficile infection (CDI) contributes to a prolongation of length of stay (LOS). Recent literature suggests that models previously used to determine LOS due to infection have overestimated LOS, compared to newer statistical models. The purpose of this review is to understand the impact that CDI has on LOS and in doing so, describe the methodological approaches used.

Aim

First, to investigate and describe the reported prolongation of LOS in hospitalised patients with CDI. Second, to describe the methodologies used for determining excess LOS.

Methods

An integrative review method was used. Papers were reviewed and analysed individually and themes were combined using integrative methods.

Results

Findings from all studies suggested that CDI contributes to a longer LOS in hospital. In studies that compared persons with and without CDI, the difference in the LOS between the two groups ranged from 2.8days to 16.1days. Potential limitations with data analysis were identified, given that no study fully addressed the issue of a time-dependent bias when examining the LOS. Recent literature suggests that a multi-state model should be used to manage the issue of time-dependent bias.

Conclusion

Studies examining LOS attributed to CDI varied considerably in design and data collected. Future studies examining LOS related to CDI and other healthcare associated infections should consider capturing the timing of infection in order to be able to employ a multi-state model for data analysis.
Appendix
Available only for authorised users
Literature
1.
go back to reference Kelly C, LaMont J: Clostridium difficile - more difficult than ever. N Eng J Med. 2008, 359: 1932-1940. 10.1056/NEJMra0707500.CrossRef Kelly C, LaMont J: Clostridium difficile - more difficult than ever. N Eng J Med. 2008, 359: 1932-1940. 10.1056/NEJMra0707500.CrossRef
2.
go back to reference Zilberberg M, Shorr A, Kollef M: Increase in adult Clostridium difficile-related hospitalizations and case-fatality rate, United States, 20002005. Emerging Infectious Dis. 2008, 14: 929-931. 10.3201/eid1406.071447.CrossRef Zilberberg M, Shorr A, Kollef M: Increase in adult Clostridium difficile-related hospitalizations and case-fatality rate, United States, 20002005. Emerging Infectious Dis. 2008, 14: 929-931. 10.3201/eid1406.071447.CrossRef
3.
go back to reference Kyne L, Hamel M, Polavaram R, Kelly C: Health Care Costs and Mortality Associated with Nosocomial Diarrhea Due to Clostridium difficile. Clin Infect Dis. 2002, 34: 346-353. 10.1086/338260.CrossRefPubMed Kyne L, Hamel M, Polavaram R, Kelly C: Health Care Costs and Mortality Associated with Nosocomial Diarrhea Due to Clostridium difficile. Clin Infect Dis. 2002, 34: 346-353. 10.1086/338260.CrossRefPubMed
4.
go back to reference Ghantoji SS, Sail K, Lairson DR, DuPont HL, Garey KW: Economic healthcare costs of Clostridium difficile infection: a systematic review. J Hosp Infect. 2010, 74: 309-318. 10.1016/j.jhin.2009.10.016.CrossRefPubMed Ghantoji SS, Sail K, Lairson DR, DuPont HL, Garey KW: Economic healthcare costs of Clostridium difficile infection: a systematic review. J Hosp Infect. 2010, 74: 309-318. 10.1016/j.jhin.2009.10.016.CrossRefPubMed
5.
go back to reference Graves N, Harbarth S, Beyersmann J, Barnett A, Halton K, Cooper B: Estimating the cost of health care-associated infections: mind your ps and qs. Clin Infect Dis. 2010, 50: 1017-1021. 10.1086/651110.CrossRefPubMed Graves N, Harbarth S, Beyersmann J, Barnett A, Halton K, Cooper B: Estimating the cost of health care-associated infections: mind your ps and qs. Clin Infect Dis. 2010, 50: 1017-1021. 10.1086/651110.CrossRefPubMed
6.
go back to reference Barnett AG, Batra R, Graves N, Edgeworth J, Robotham J, Cooper B: Using a Longitudinal Model to Estimate the Effect of Methicillin-resistant Staphylococcus aureus Infection on Length of Stay in an Intensive Care Unit. Am J Epidemiol. 2009, 170: 1186-1194. 10.1093/aje/kwp249.CrossRefPubMed Barnett AG, Batra R, Graves N, Edgeworth J, Robotham J, Cooper B: Using a Longitudinal Model to Estimate the Effect of Methicillin-resistant Staphylococcus aureus Infection on Length of Stay in an Intensive Care Unit. Am J Epidemiol. 2009, 170: 1186-1194. 10.1093/aje/kwp249.CrossRefPubMed
7.
go back to reference Beyersmann J, Gastmeier P, Wolkewitz M, Schumacher M: An easy mathematical proof showed that time-dependent bias inevitably leads to biased effect estimation. J Clin Epidemiol. 2008, 61: 1216-1221. 10.1016/j.jclinepi.2008.02.008. Epub 2008 Jul 1210CrossRefPubMed Beyersmann J, Gastmeier P, Wolkewitz M, Schumacher M: An easy mathematical proof showed that time-dependent bias inevitably leads to biased effect estimation. J Clin Epidemiol. 2008, 61: 1216-1221. 10.1016/j.jclinepi.2008.02.008. Epub 2008 Jul 1210CrossRefPubMed
8.
go back to reference Beyersmann J, Kneib T, Schumacher M, Gastmeier P: Nosocomial infection, length of stay, and time-dependent bias. Infect Control Hosp Epidemiol. 2009, 30: 273-276. 10.1086/596020.CrossRefPubMed Beyersmann J, Kneib T, Schumacher M, Gastmeier P: Nosocomial infection, length of stay, and time-dependent bias. Infect Control Hosp Epidemiol. 2009, 30: 273-276. 10.1086/596020.CrossRefPubMed
9.
go back to reference Beyersmann J, Wolkewitz M, Schumacher M: The impact of time-dependent bias in proportional hazards modelling. Stat Med. 2008, 27: 6439-6454. 10.1002/sim.3437.CrossRefPubMed Beyersmann J, Wolkewitz M, Schumacher M: The impact of time-dependent bias in proportional hazards modelling. Stat Med. 2008, 27: 6439-6454. 10.1002/sim.3437.CrossRefPubMed
10.
go back to reference Graves N, Weinhold D, Tong E, Birrell F, Doidge S, Ramritu P, Halton K, Lairson D, Whitby M: Effect of healthcare-acquired infection on length of hospital stay and cost. Infect Control Hosp Epidemiol. 2007, 28: 280-292. 10.1086/512642. Epub 2007 Feb 2020CrossRefPubMed Graves N, Weinhold D, Tong E, Birrell F, Doidge S, Ramritu P, Halton K, Lairson D, Whitby M: Effect of healthcare-acquired infection on length of hospital stay and cost. Infect Control Hosp Epidemiol. 2007, 28: 280-292. 10.1086/512642. Epub 2007 Feb 2020CrossRefPubMed
11.
go back to reference van Walraven C, Davis D, Forster AJ, Wells GA: Time-dependent bias was common in survival analyses published in leading clinical journals. J Clin Epidemiol. 2004, 57: 672-682. 10.1016/j.jclinepi.2003.12.008.CrossRefPubMed van Walraven C, Davis D, Forster AJ, Wells GA: Time-dependent bias was common in survival analyses published in leading clinical journals. J Clin Epidemiol. 2004, 57: 672-682. 10.1016/j.jclinepi.2003.12.008.CrossRefPubMed
12.
go back to reference van Walraven C, Seth R, Austin PC, Laupaci A: Effect of Discharge Summary Availability During Post-discharge Visits on Hospital Readmission. J Gen Intern Med. 2002, 17: 186-192. 10.1046/j.1525-1497.2002.10741.x.PubMedCentralCrossRefPubMed van Walraven C, Seth R, Austin PC, Laupaci A: Effect of Discharge Summary Availability During Post-discharge Visits on Hospital Readmission. J Gen Intern Med. 2002, 17: 186-192. 10.1046/j.1525-1497.2002.10741.x.PubMedCentralCrossRefPubMed
13.
go back to reference Wolkewitz M, Allignol A, Schumacher M, Beyersmann J: Two Pitfalls in Survival Analyses of Time-Dependent Exposure: A Case Study in a Cohort of Oscar Nominees. Am Stat. 2010, 64: 205-211. 10.1198/tast.2010.08259.CrossRef Wolkewitz M, Allignol A, Schumacher M, Beyersmann J: Two Pitfalls in Survival Analyses of Time-Dependent Exposure: A Case Study in a Cohort of Oscar Nominees. Am Stat. 2010, 64: 205-211. 10.1198/tast.2010.08259.CrossRef
14.
go back to reference Barnett AG, Beyersmann J, Allignol A, Rosenthal VD, Graves N, Wolkewitz M: The time-dependent bias and its effect on extra length of stay due to nosocomial infection. Value Health. 2011, 14: 381-386. 10.1016/j.jval.2010.09.008.CrossRefPubMed Barnett AG, Beyersmann J, Allignol A, Rosenthal VD, Graves N, Wolkewitz M: The time-dependent bias and its effect on extra length of stay due to nosocomial infection. Value Health. 2011, 14: 381-386. 10.1016/j.jval.2010.09.008.CrossRefPubMed
15.
go back to reference Whittemore R, Knafl K: The integrative review: updated methodology. J Adv Nurs. 2005, 52: 546-553. 10.1111/j.1365-2648.2005.03621.x.CrossRefPubMed Whittemore R, Knafl K: The integrative review: updated methodology. J Adv Nurs. 2005, 52: 546-553. 10.1111/j.1365-2648.2005.03621.x.CrossRefPubMed
16.
go back to reference Ananthakrishnan AN, McGinley EL, Binion DG: Excess hospitalisation burden associated with Clostridium difficile in patients with inflammatory bowel disease. Gut. 2008, 57: 205-210. 10.1136/gut.2007.128231.CrossRefPubMed Ananthakrishnan AN, McGinley EL, Binion DG: Excess hospitalisation burden associated with Clostridium difficile in patients with inflammatory bowel disease. Gut. 2008, 57: 205-210. 10.1136/gut.2007.128231.CrossRefPubMed
17.
go back to reference Bhangu S, Bhangu A, Nightingale P, Michael A: Mortality and risk stratification in patients with Clostridium difficile-associated diarrhoea. Colorectal Dis. 2010, 12: 241-246. 10.1111/j.1463-1318.2009.01832.x.CrossRefPubMed Bhangu S, Bhangu A, Nightingale P, Michael A: Mortality and risk stratification in patients with Clostridium difficile-associated diarrhoea. Colorectal Dis. 2010, 12: 241-246. 10.1111/j.1463-1318.2009.01832.x.CrossRefPubMed
18.
go back to reference Nguyen GC, Kaplan GG, Harris ML, Brant SR: A national survey of the prevalence and impact of Clostridium difficile infection among hospitalized inflammatory bowel disease patients. Am J Gastroenterol. 2008, 103: 1443-1450. 10.1111/j.1572-0241.2007.01780.x.CrossRefPubMed Nguyen GC, Kaplan GG, Harris ML, Brant SR: A national survey of the prevalence and impact of Clostridium difficile infection among hospitalized inflammatory bowel disease patients. Am J Gastroenterol. 2008, 103: 1443-1450. 10.1111/j.1572-0241.2007.01780.x.CrossRefPubMed
19.
go back to reference OBrien JA, Lahue BJ, Caro JJ, Davidson DM: The emerging infectious challenge of clostridium difficile-associated disease in Massachusetts hospitals: clinical and economic consequences. Infect Control Hosp Epidemiol. 2007, 28: 1219-1227. 10.1086/522676.CrossRef OBrien JA, Lahue BJ, Caro JJ, Davidson DM: The emerging infectious challenge of clostridium difficile-associated disease in Massachusetts hospitals: clinical and economic consequences. Infect Control Hosp Epidemiol. 2007, 28: 1219-1227. 10.1086/522676.CrossRef
20.
go back to reference Zerey M, Paton BL, Lincourt AE, Gersin KS, Kercher KW, Heniford BT: The burden of Clostridium difficile in surgical patients in the United States. Surg Infect. 2007, 8: 557-566. 10.1089/sur.2006.062.CrossRef Zerey M, Paton BL, Lincourt AE, Gersin KS, Kercher KW, Heniford BT: The burden of Clostridium difficile in surgical patients in the United States. Surg Infect. 2007, 8: 557-566. 10.1089/sur.2006.062.CrossRef
21.
go back to reference Zilberberg MD, Nathanson BH, Sadigov S, Higgins TL, Kollef MH, Shorr AF: Epidemiology and outcomes of clostridium difficile-associated disease among patients on prolonged acute mechanical ventilation. Chest. 2009, 136: 752-758. 10.1378/chest.09-0596.PubMed Zilberberg MD, Nathanson BH, Sadigov S, Higgins TL, Kollef MH, Shorr AF: Epidemiology and outcomes of clostridium difficile-associated disease among patients on prolonged acute mechanical ventilation. Chest. 2009, 136: 752-758. 10.1378/chest.09-0596.PubMed
22.
go back to reference Dubberke ER, Wertheimer AI: Review of current literature on the economic burden of Clostridium difficile infection. Infect Control Hosp Epidemiol. 2009, 30: 57-66. 10.1086/592981.CrossRefPubMed Dubberke ER, Wertheimer AI: Review of current literature on the economic burden of Clostridium difficile infection. Infect Control Hosp Epidemiol. 2009, 30: 57-66. 10.1086/592981.CrossRefPubMed
23.
go back to reference Riley TV, Codde JP, Rouse IL: Increased length of hospital stay due to Clostridium difficile associated diarrhoea. Lancet. 1995, 345: 455-456.CrossRefPubMed Riley TV, Codde JP, Rouse IL: Increased length of hospital stay due to Clostridium difficile associated diarrhoea. Lancet. 1995, 345: 455-456.CrossRefPubMed
24.
go back to reference Dubberke ER, Butler AM, Reske KA, Agniel D, Olsen MA, DAngelo G, McDonald LC, Fraser VJ: Attributable outcomes of endemic Clostridium difficile-associated disease in nonsurgical patients. Emerg Infect Dis. 2008, 14: 1031-1038. 10.3201/eid1407.070867.PubMedCentralCrossRefPubMed Dubberke ER, Butler AM, Reske KA, Agniel D, Olsen MA, DAngelo G, McDonald LC, Fraser VJ: Attributable outcomes of endemic Clostridium difficile-associated disease in nonsurgical patients. Emerg Infect Dis. 2008, 14: 1031-1038. 10.3201/eid1407.070867.PubMedCentralCrossRefPubMed
25.
go back to reference Pepin J, Valiquette L, Cossette B: Mortality attributable to nosocomial Clostridium difficile-associated disease during an epidemic caused by a hypervirulent strain in Quebec. CMAJ. 2005, 173: 1037-1042. 10.1503/cmaj.050978.PubMedCentralCrossRefPubMed Pepin J, Valiquette L, Cossette B: Mortality attributable to nosocomial Clostridium difficile-associated disease during an epidemic caused by a hypervirulent strain in Quebec. CMAJ. 2005, 173: 1037-1042. 10.1503/cmaj.050978.PubMedCentralCrossRefPubMed
26.
go back to reference Kenneally C, Rosini JM, Skrupky LP, Doherty JA, Hollands JM, Martinez E, McKinzie WE, Murphy T, Smith JR, Micek ST, Kollef MH: Analysis of 30-day mortality for clostridium difficile-associated disease in the ICU setting.[Erratum appears in Chest. Nov;132(5):1721 Note: McKenzie, Wendi [corrected to McKinzie, Wendi E]]. Chest. 2007, 2007 (132): 418-424.CrossRef Kenneally C, Rosini JM, Skrupky LP, Doherty JA, Hollands JM, Martinez E, McKinzie WE, Murphy T, Smith JR, Micek ST, Kollef MH: Analysis of 30-day mortality for clostridium difficile-associated disease in the ICU setting.[Erratum appears in Chest. Nov;132(5):1721 Note: McKenzie, Wendi [corrected to McKinzie, Wendi E]]. Chest. 2007, 2007 (132): 418-424.CrossRef
27.
go back to reference Lawrence SJ, Puzniak LA, Shadel BN, Gillespie KN, Kollef MH, Mundy LM: Clostridium difficile in the intensive care unit: epidemiology, costs, and colonization pressure. Infect Control Hosp Epidemiol. 2007, 28: 123-130. 10.1086/511793.CrossRefPubMed Lawrence SJ, Puzniak LA, Shadel BN, Gillespie KN, Kollef MH, Mundy LM: Clostridium difficile in the intensive care unit: epidemiology, costs, and colonization pressure. Infect Control Hosp Epidemiol. 2007, 28: 123-130. 10.1086/511793.CrossRefPubMed
28.
go back to reference Lumpkins K, Bochicchio GV, Joshi M, Gens R, Bochicchio K, Conway A, Schaub S, Scalea T: Clostridium difficile infection in critically injured trauma patients. Surg Infect. 2008, 9: 497-501. 10.1089/sur.2007.071.CrossRef Lumpkins K, Bochicchio GV, Joshi M, Gens R, Bochicchio K, Conway A, Schaub S, Scalea T: Clostridium difficile infection in critically injured trauma patients. Surg Infect. 2008, 9: 497-501. 10.1089/sur.2007.071.CrossRef
29.
go back to reference Bajaj JS, Ananthakrishnan AN, Hafeezullah M, Zadvornova Y, Dye A, McGinley EL, Saeian K, Heuman D, Sanyal AJ, Hoffmann RG: Clostridium difficile is associated with poor outcomes in patients with cirrhosis: a national and tertiary center perspective. Am J Gastroenterol. 2010, 105: 106-113. 10.1038/ajg.2009.615.CrossRefPubMed Bajaj JS, Ananthakrishnan AN, Hafeezullah M, Zadvornova Y, Dye A, McGinley EL, Saeian K, Heuman D, Sanyal AJ, Hoffmann RG: Clostridium difficile is associated with poor outcomes in patients with cirrhosis: a national and tertiary center perspective. Am J Gastroenterol. 2010, 105: 106-113. 10.1038/ajg.2009.615.CrossRefPubMed
30.
go back to reference Song X, Bartlett JG, Speck K, Naegeli A, Carroll K, Perl TM: Rising economic impact of clostridium difficile-associated disease in adult hospitalized patient population. Infect Control Hosp Epidemiol. 2008, 29: 823-828. 10.1086/588756.CrossRefPubMed Song X, Bartlett JG, Speck K, Naegeli A, Carroll K, Perl TM: Rising economic impact of clostridium difficile-associated disease in adult hospitalized patient population. Infect Control Hosp Epidemiol. 2008, 29: 823-828. 10.1086/588756.CrossRefPubMed
31.
go back to reference Graves N, Halton K, Jarvis W: Economics and Preventing Heatlhcare Acquired Infection. 2009, Springer, New YorkCrossRef Graves N, Halton K, Jarvis W: Economics and Preventing Heatlhcare Acquired Infection. 2009, Springer, New YorkCrossRef
32.
go back to reference Roberts RR, Frutos PW, Ciavarella GG, Gussow LM, Mensah EK, Kampe LM, Straus HE, Joseph G, Rydman RJ: Distribution of variable vs fixed costs of hospital care. JAMA. 1999, 281: 644-649. 10.1001/jama.281.7.644.CrossRefPubMed Roberts RR, Frutos PW, Ciavarella GG, Gussow LM, Mensah EK, Kampe LM, Straus HE, Joseph G, Rydman RJ: Distribution of variable vs fixed costs of hospital care. JAMA. 1999, 281: 644-649. 10.1001/jama.281.7.644.CrossRefPubMed
33.
go back to reference Plowman R, Graves N, Griffin A, Roberts J, Swan A, Cookson B, Taylor L: The socioeconomic burden of hospital acquired infection. Book The socioeconomic burden of hospital acquired infection. 1999, Department of Health, City Plowman R, Graves N, Griffin A, Roberts J, Swan A, Cookson B, Taylor L: The socioeconomic burden of hospital acquired infection. Book The socioeconomic burden of hospital acquired infection. 1999, Department of Health, City
34.
go back to reference Beyersmann J: A random time interval approach for analysing the impact of a possible intermediate event on a terminal event. Biom J. 2007, 49: 742-749. 10.1002/bimj.200610342.CrossRefPubMed Beyersmann J: A random time interval approach for analysing the impact of a possible intermediate event on a terminal event. Biom J. 2007, 49: 742-749. 10.1002/bimj.200610342.CrossRefPubMed
35.
go back to reference Forster AJ, Taljaard M, Oake N, Wilson K, Roth V, van Walraven C: The effect of hospital-acquired infection with Clostridium difficile on length of stay in hospital. Can Med Assoc J. 2012, 184: 37-42. 10.1503/cmaj.110543.CrossRef Forster AJ, Taljaard M, Oake N, Wilson K, Roth V, van Walraven C: The effect of hospital-acquired infection with Clostridium difficile on length of stay in hospital. Can Med Assoc J. 2012, 184: 37-42. 10.1503/cmaj.110543.CrossRef
36.
go back to reference Beyersmann J, Gastmeier P, Grundmann H, Barwolff S, Geffers C: Use of multistate models to assess prolongation of intensive care unit stay due to nosocomial infection. 2006, University of Chicago Press, Chicago, IL, ETATS-UNIS Beyersmann J, Gastmeier P, Grundmann H, Barwolff S, Geffers C: Use of multistate models to assess prolongation of intensive care unit stay due to nosocomial infection. 2006, University of Chicago Press, Chicago, IL, ETATS-UNIS
Metadata
Title
Prolongation of length of stay and Clostridium difficile infection: a review of the methods used to examine length of stay due to healthcare associated infections
Authors
Brett G Mitchell
Anne Gardner
Publication date
01-12-2012
Publisher
BioMed Central
Published in
Antimicrobial Resistance & Infection Control / Issue 1/2012
Electronic ISSN: 2047-2994
DOI
https://doi.org/10.1186/2047-2994-1-14

Other articles of this Issue 1/2012

Antimicrobial Resistance & Infection Control 1/2012 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.